Cargando…

Thrombotic Events in COVID-19 Patients Undergoing Convalescent Plasma Therapy: A Systematic Review

INTRODUCTION Convalescent plasma therapy (CPT) has been proposed as a mechanism of passive immunization against COVID-19. Current guidelines on the efficacy of its use is not well delineated with limited studies analyzing the risk of thromboembolic events during treatment. The goal of this systemati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Philip, Khalid, Faran, Li, Allen, Laureano, Marissa, Crowther, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2021
Materias:	331.Thrombosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701518/ http://dx.doi.org/10.1182/blood-2021-153374

Ejemplares similares

Comparison of Thrombotic Complications in Critically Ill Patients between COVID-19 and Mers-COV
por: Al Raizah, Abdulrahman, et al.
Publicado: (2021)

Post-Covid-19 Hemostatic Characteristics of Convalescent Patients: The Bergamo Experience
por: Tartari, Carmen Julia J, et al.
Publicado: (2021)

The Impact of Degree of Anticoagulation on Thrombotic and Other Complications in Hospitalized COVID-19 Patients
por: Zheng, Rena, et al.
Publicado: (2021)

Vaccine-Induced Thrombotic Thrombocytopenia: Novelty Testing in the Diagnostic Work-up?
por: Cacciola, Rossella Rosari, et al.
Publicado: (2021)

A Rare Case of Mild COVID-19 Disease Associated with Type 1 Cryoglobulinemia and Thrombotic Thrombocytopenic Purpura
por: Naqvi, Syed Mujtaba, et al.
Publicado: (2021)

COVID-19 Diagnosis and Its Impact on Thrombotic Risk in a Cohort of Patients Simultaneously Hospitalized Due to Acute Respiratory Distress Syndrome
por: Coy-Canguçu, Andréa, et al.
Publicado: (2021)

Thrombotic Events in COVID-19 Patients and Its Comparison with Other Non-Sars-Cov-2 Respiratory Viruses
por: Tan, Jing Yuan, et al.
Publicado: (2020)

COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2021)

Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis
por: Madeeva, Daria V, et al.
Publicado: (2021)

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Thrombocytopenia with and without Thrombosis Following COVID-19 Vaccination
por: Ge, Melissa, et al.
Publicado: (2021)

Deep Vein Thrombosis after COVID-19 Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2021)

An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy
por: Kaufman, Adrienne, et al.
Publicado: (2021)

Does Fibrin Structure Contribute to the Increased Risk of Thrombosis in COVID-19 ICU Patients?
por: De Vries, Judith Juliana, et al.
Publicado: (2021)

The Correlation between Racial/Ethnic Groups, Thrombosis, and Mortality in Hospitalized Patients with COVID-19
por: Rodriguez, Maya, et al.
Publicado: (2021)

Biomarkers for Thrombosis in COVID-19: A Role for High Sensitivity Troponin-I and Immature Platelet Fraction?
por: Ashraf, Bilal, et al.
Publicado: (2021)

Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study
por: Stevens, Hannah P, et al.
Publicado: (2021)

Risk Stratification for Acute Arterial and Venous Thromboembolism using CHA (2)DS (2)-VASc Score in Hospitalized COVID-19 Patients: A Multicenter Study
por: Lee, Yi, et al.
Publicado: (2021)

Comparison of D-Dimer Level on Mild, Moderate and Severe COVID-19 at Immanuel Hospital Bandung City October 1 (st) - December 31 (st), 2020
por: Gustian, Hary, et al.
Publicado: (2021)

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
por: Singh, Bandana, et al.
Publicado: (2021)

Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis
por: Zhang, Cong, et al.
Publicado: (2020)

Clinical Trial to Evaluate an Approved ITP Therapy Targeting Spleen Tyrosine Kinase (SYK) for Prevention and Treatment of COVID-19 Related Complications
por: Dummer, Wolfgang, et al.
Publicado: (2020)

Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry
por: Giannis, Dimitrios, et al.
Publicado: (2020)

Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism
por: Li, Pei Ye, et al.
Publicado: (2023)

Thrombosis and Mortality in Pregnant Patients with COVID-19
por: Behrens, Elizabeth, et al.
Publicado: (2020)

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
por: Warrior, Surbhi, et al.
Publicado: (2020)

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study
por: Van Dreden, Patrick, et al.
Publicado: (2020)

Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

COVID-19 Thrombosis: Understanding the Negative Predictive Value in a Pandemic
por: Almukhtar, Talat, et al.
Publicado: (2020)

Hematology Consultations during the COVID-19 Pandemic at a University Medical Center
por: Choi, Daniel C, et al.
Publicado: (2020)

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19
por: Gerotziafas, Grigoris, et al.
Publicado: (2020)

Extensive Characterization of the Hemostatic Derangement Occurring in COVID-19 Patients Admitted to the Bergamo Hospital
por: Gomez-Rosas, Patricia, et al.
Publicado: (2020)

Association between ROTEM Hypercoagulable Profile and Outcome in a Cohort of Severely Ill COVID-19 Patients Under Mechanical Ventilation
por: Ratano, Damian, et al.
Publicado: (2020)

Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis?
por: Marquez, Félix Gibrant, et al.
Publicado: (2020)

Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults
por: Mitchell, William Beau, et al.
Publicado: (2020)

Inflammation Drives Coagulopathies in Sars-Cov-2 Patients
por: Sim, Martha MS, et al.
Publicado: (2020)

Immunosuppressive Treatment Does Not Prevent Humoral and Cellular Virus-Specific Immunity in Heart or Lung Recipients with SARS-CoV-2 Pneumonia
por: Seminari, E., et al.
Publicado: (2021)

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
por: Berkowitz, Scott D., et al.
Publicado: (2022)

Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
por: Kaptein, Fleur H. J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dh1urr3p305kic4led76io30an